Deals, Insight journal - Dealtalk

Nycomed eyes emerging markets boost to 60% of sales

Posted on 07 March 2011

Tags: , ,

Nycomed execs are following their Big Pharma brethren in promising big growth in emerging markets.

They're also echoing the bigger drugmakers with laments about losing sales to new generic competition to big products, in this case, the stomach drug Protonix...

Read the full Nycomed story at PharmaTimes

 

Print Friendly, PDF & Email

Leave a Reply